# Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.

> **NCT03972748** · NA · UNKNOWN · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 28 (estimated)

## Conditions studied

- Basal Cell Carcinoma
- Hedgehog Pathway

## Interventions

- **DRUG:** Itraconazole 200 mg

## Key facts

- **NCT ID:** NCT03972748
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-05
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2019-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972748, "Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03972748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*